Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers

NCT05621655 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1512

Enrollment

INDUSTRY

Sponsor class

Conditions

Rotavirus Infections
Rotavirus Gastroenteritis

Interventions

BIOLOGICAL: Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
BIOLOGICAL: High dose Recombinant Trivalent Subunit Rotavirus Vaccine
BIOLOGICAL: Placebo

Sponsor

MAXVAX Biotechnology Limited Liability Company

Collaborators

[object Object]